Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 17Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Helsinn and Angelini Pharma renew distribution deal
Helsinn and Angelini Pharma renew distribution deal

28 May 2024

// PHARMACEUTICAL TECHNOLOGY

https://www.pharmaceutical-technology.com/news/helsinn-angelini-distribution-deal/

PHARMACEUTICAL TECHNOLOGY
28 May 2024

https://www.pharmacompass.com/pdf/news/brainfarmas-batch-of-nimesulide-is-forbidden-by-anvisa-1502939899.pdf

ANVISA
14 Aug 2017

http://www.reuters.com/article/us-health-nsaids-heart-failure-idUSKCN12K2J1

REUTERS
21 Oct 2016

http://twofourinsight.com/experts-review-banned-drugs-consider-marketing-restrictions-india-mhfw/

TWO FOUR INSIGHT
26 Apr 2016

http://www.pharma-excipients.ch/2016/03/27/impact-of-degree-of-substitution-of-acetylated-ofada-rice-starchpolymer-on-the-release-properties-of-nimesulide-microspheres/

PHARMA-EXCIPIENTS
27 Mar 2016

http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/40-doctors-disagree-with-governments-recent-drug-ban-list-survey/articleshow/51459620.cms

ECONOMIC TIMES
18 Mar 2016